
NLS Pharmaceutics is a biotechnology company in the healthcare sector on NASDAQ, led by Alexander Zwyer, with a market cap of $4.0M. As of Q3 2025, 0% of shares are held by 1 institutional investors, with CoreCap Advisors, LLC as the largest holder at 0.001%.
Overview of institutional ownership in NLSP as of Q3 2025 with a market cap of $7.8M
Based on market cap of $7.8M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Institutions with the largest positions in NLSP as of Q3 2025
| Institution | Position Value |
|---|---|
CoreCap Advisors, LLC RIA/Wealth | $66.0 0.00% of portfolio |
UBS Group AG Institution | - 0.00% of portfolio |
MORGAN STANLEY RIA/Wealth | - 0.00% of portfolio |
B BVF INC/IL Institution | - 0.00% of portfolio |
Institutional buying and selling activity for NLSP in Q3 2025
| Institution | Net Bought | |
|---|---|---|
| No buyers found | ||
| Institution | Net Sold |
|---|---|
B BVF INC/IL Institution | −$416.7K −143.7K shares |
UBS Group AG Institution | −$43.4K −15.0K shares |
MORGAN STANLEY RIA/Wealth | −$7.3K −2.5K shares |
Institutions that initiated new positions or completely exited NLSP in Q3 2025
| Institution | Position Value |
|---|---|
| No new positions found | |
| Institution | Previous Position |
|---|---|
B BVF INC/IL Institution | $416.7K 143.7K shares |
UBS Group AG Institution | $43.4K 15.0K shares |
MORGAN STANLEY RIA/Wealth | $7.3K 2.5K shares |
Institutions with the largest Call and Put options positions in NLSP as of Q3 2025
| Institution | Position Value |
|---|---|
| No call positions found | |
| Institution | Position Value |
|---|---|
| No put positions found | |
Institutions with NLSP as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
CoreCap Advisors, LLC RIA/Wealth | 0.00% $66.0 |
UBS Group AG Institution | 0.00% - |
MORGAN STANLEY RIA/Wealth | 0.00% - |
B BVF INC/IL Institution | 0.00% - |
We use cookies for analytics. See our Privacy and Cookie Policy.